Literature DB >> 33483816

Factors Associated with Osteoporosis Management Among Veterans Who Received Androgen Deprivation Therapy for Prostate Cancer.

Samantha L Solimeo1,2,3,4, Brian C Lund5,6, Kimberly D McCoy5,7, Mary Vaughan Sarrazin5,7,8, Richard Hoffman7,8,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33483816      PMCID： PMC8481523          DOI： 10.1007/s11606-020-06418-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

1.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

2.  Limited Osteoporosis Screening Effectiveness Due to Low Treatment Rates in a National Sample of Older Men.

Authors:  Cathleen S Colón-Emeric; Carl F Pieper; Courtney H Van Houtven; Janet M Grubber; Kenneth W Lyles; Joanne Lafleur; Robert A Adler
Journal:  Mayo Clin Proc       Date:  2018-12       Impact factor: 7.616

Review 3.  Primary Care of the Prostate Cancer Survivor.

Authors:  Erika M Noonan; Timothy W Farrell
Journal:  Am Fam Physician       Date:  2016-05-01       Impact factor: 3.292

4.  Prostate cancer survivorship care in the Veterans Health Administration.

Authors:  Ted A Skolarus; Sarah T Hawley
Journal:  Fed Pract       Date:  2014-08

5.  Erratum to: Clinician's guide to prevention and treatment of osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2015-07       Impact factor: 4.507
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.